Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 37

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 37
---
, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein. The address for these individuals and entities is 2740 Sand Hill Road, 2 ndFloor, Menlo Park, California 94025. The foregoing information was obtained from a Schedule 13D/A filed on November 4, 2024.

| (3) | The number of shares reported and the information included in this footnote was obtained from a Schedule 13G filed on November 14, 2024 by T. Rowe Price Associates, Inc. According to the Schedule 13G, T. Rowe Price Associates, Inc. beneficially owns 3,939,109 shares of Class A common stock, with sole dispositive power over all such shares and sole voting power over 3,872,775 shares. The address for T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202. |

| (4) | Consists of (i) 65,476 shares of Class A common stock held directly by Dr. Fordyce, (ii) 222,030 shares of Class A common stock held by MWF 2024 Annuity Trust, of which Dr. Fordyce is trustee and exercises sole voting and sole dispositive power over such shares and (iii) 1,219,568 shares of Class A common stock subject to options exercisable within 60 days of the Record Date held by Dr. Fordyce. |

| (5) | Consists of (i) 1,198 shares of Class A common stock held directly by Dr. Brenner and (ii) 118,907 shares of Class A common stock subject to options exercisable within 60 days of the Record Date held by Dr. Brenner. |

| (6) | Consists of (i) 17,488 shares of Class A common stock held by the Andrew Cheng 2010 Trust UA 10-26-2010, of which Dr. Cheng is trustee and exercises sole voting and sole dispositive power over such shares and (ii) 122,893 shares of Class A common stock subject to options exercisable within 60 days of the Record Date held by Dr. Cheng. |

| (7) | Consists of (i) 4,012 shares of Class A common stock held by the Samuel B. Seidenberg Irrevocable Trust, established July